• UPM3TM is based on a specific gene PCA3

• PCA3 is over-expressed in prostate cancer tissue (average 34fold, range 10-100-fold) compared to benign prostate tissue

• No other human tissues have ever been shown to produce PCA3.

• The DD3PCA3 gene is located at chromosome 9q21-22 and even minute amounts in urine can be detected using a nucleic acid amplification assay

• Following prostatic massage, the first 10-20 mL of urine is collected and tested for DD3PCA3, which is over-expressed in 95% of CAP and therefore CAP-specific

• This is a relatively new test requiring specialized laboratory facilities and experience in a routine clinical setting is limited

• Detection depends on prostate cancer cells shed in the urine after prostate massage, which then need to be transported to the laboratory, resulting in potential loss of specimen quality

• Represents an exciting and promising non-invasive technique for the investigation of men with suspected CAP

The reported sensitivity and specificities of the uPM3 assay are as described in Table 1.13.

• UPM3 appears to be twice as specific as PSA for the detection of CAP, especially in men with a PSA <10 ng/L

• Up to 75% of men with a positive uPM3 test will go on have histological evidence of CAP following transrectal biopsy

• In addition, uPM3 seems to be a better predictor of outcome in patients undergoing a repeat prostate biopsy

Chapter 2

Was this article helpful?

0 0
Dealing With Erectile Dysfunction

Dealing With Erectile Dysfunction

Whether you call it erectile dysfunction, ED, impotence, or any number of slang terms, erection problems are something many men have to face during the course of their lifetimes.

Get My Free Ebook

Post a comment